Long before scientists test new medicines in animals or people, they study the effects of the substances on cells growing in Petri dishes. However, a 2D layer of cells is a poor substitute for the much more complex 3D structure of tissues in organs. Now, researchers reporting in the ACS jou ... more
Sniffing out Parkinson's disease
Parkinson's disease is a neurodegenerative disorder that leads to progressive brain cell death and extensive loss of motor function. Despite much research being conducted on this disease, there are no definitive diagnostic tests currently available. Now, researchers report the identification of compounds that make up the signature odor of the disease with the help an individual who can detect Parkinson's through smell. They report their findings in ACS Central Science.
Ancient physicians used scent as a diagnostic tool, and although olfactory tests are not common in modern medicine, diseases such as diabetes are often associated with a particular smell. However, there has been little evidence to tie scent to neurodegenerative disorders. Enter Joy Milne, a "Super Smeller" who can distinguish the unique odor of Parkinson's, which she can detect in subjects' sebum before clinical symptoms appear. This waxy, lipid-based biofluid moisturizes and protects the skin, particularly on the forehead and upper back. Excessive production of the substance is a known symptom of Parkinson's disease. So, Perdita Barran and colleagues wanted to determine what chemicals make up the scent in sebum that Milne is picking up on in Parkinson's patients so that they can eventually develop a diagnostic test for the disease.
The researchers collected sebum samples using gauze to swab the upper backs of more than 60 subjects, both with and without Parkinson's. The volatile scent compounds of sebum that could be contributing to a disease-associated smell were extracted and analyzed with mass spectrometry. The data revealed the presence of hippuric acid, eicosane and octadecanal, which indicate the altered levels of neurotransmitters found in Parkinson's patients, along with several other biomarkers for the disease. Milne confirmed the signature musk of Parkinson's when presented with laboratory-prepared samples containing these compounds in a controlled olfactory environment. While the researchers acknowledge the limited scope of this study, they say it opens the door to the development of a non-invasive screening test for Parkinson's, potentially leading to earlier detection.
- Parkinson's disease
- mass spectrometry
Like other biofluids, sweat contains a wealth of information about what's going on inside the body. However, collecting the fluid for analysis, usually by dripping or absorbing it from the skin's surface, can be time-consuming and messy. Now, researchers have developed a bandage-like biosen ... more
For decades, forensic scientists have tested strands of hair to reveal drug use or poisoning. But in recent years, reports have questioned the technique -- in particular, its ability to distinguish between the intake of a substance and external contamination of the hair. Now, researchers ha ... more
The products we use every day leave behind chemical footprints. Learn how and why researchers are now studying those trails. Mass spectrometry is helping researchers learn more about our interactions with the everyday chemicals we use, such as DEET, caffeine, even medications. In this episo ... more
- 1The Art of Sensing within the Skin
- 2How do atoms vibrate in graphene nanostructures?
- 3For salmonella detection, genomic tool emerges as a key
- 4What the brains of people with excellent general knowledge look like
- 5Bringing cancer medication safely to its destination
- 6Immune system of plants: It works differently than expected
- 717 Million for Future Cancer Diagnoses
- 8Merck Acquires laboratory informatics company
- 9Google Maps for tissues
- 10Toxin responsible for Legionella growth identified
- New, portable tech sniffs out plant disease in the field
- For salmonella detection, genomic tool emerges as a key
- Caught in the act: Images capture molecular motions in real time
- It's not an antibody, it's a frankenbody: A new tool for live-cell imaging
- X-ray imaging provides clues to fracture in solid-state batteries